Atrial Fibrillation News and Research

RSS
Atrial fibrillation (AF) is the most common arrhythmia. An arrhythmia is a problem with the speed or rhythm of the heartbeat. A disorder in the heart’s electrical system causes AF and other types of arrhythmia. AF occurs when rapid, disorganized electrical signals in the heart’s two upper chambers, called the atria, cause them to contract very fast and irregularly (this is called fibrillation). As a result, blood pools in the atria and isn’t pumped completely into the heart’s two lower chambers, called the ventricles. When this happens, the heart’s upper and lower chambers don’t work together as they should. Often, people who have AF may not even feel symptoms. However, even when not noticed, AF can lead to an increased risk of stroke. In many patients, particularly when the rhythm is extremely rapid, AF can cause chest pain, heart attack, or heart failure. AF may occur rarely or every now and then, or it may become a persistent or permanent heart rhythm lasting for years.
Robotic navigation systems in electrophysiology

Robotic navigation systems in electrophysiology

Best use of drug-eluting stents: When should they be avoided?

Best use of drug-eluting stents: When should they be avoided?

Adalat XL Plus approved in Canada

Adalat XL Plus approved in Canada

Sudden loss of hearing might be an early sign of stroke

Sudden loss of hearing might be an early sign of stroke

Beta blockers after surgery more risky than beneficial

Beta blockers after surgery more risky than beneficial

Results of St. Jude Medical deep brain stimulation study presented at APA meeting

Results of St. Jude Medical deep brain stimulation study presented at APA meeting

Fosamax use linked to atrial fibrillation in women

Fosamax use linked to atrial fibrillation in women

Alendronate may be associated with irregular heartbeat

Alendronate may be associated with irregular heartbeat

Mitochondrial dysfunction and redox signaling in atrial tachyarrhythmia

Mitochondrial dysfunction and redox signaling in atrial tachyarrhythmia

Drug does not appear to reduce risk of heart attack or death following CABG surgery

Drug does not appear to reduce risk of heart attack or death following CABG surgery

Stroke risk factors may signal faster cognitive decline in elderly

Stroke risk factors may signal faster cognitive decline in elderly

Stereotaxis announces FDA approval of magnetic irrigated catheter

Stereotaxis announces FDA approval of magnetic irrigated catheter

Exercise testing to predict mitral regurgitation

Exercise testing to predict mitral regurgitation

Exercise testing may help predict seriousness of mitral regurgitation

Exercise testing may help predict seriousness of mitral regurgitation

Study results from Zolinza (vorinostat) in combination with bortezomib for multiple myeloma trial

Study results from Zolinza (vorinostat) in combination with bortezomib for multiple myeloma trial

Atrial fibrillation screening can identify irregular heartbeat that leads to stroke

Atrial fibrillation screening can identify irregular heartbeat that leads to stroke

Stereotaxis announces first atrial fibrillation procedures performed with performed with magnetic irrigated catheter

Stereotaxis announces first atrial fibrillation procedures performed with performed with magnetic irrigated catheter

Hypertension or atrial fibrillation linked to Alzheimer's disease progression

Hypertension or atrial fibrillation linked to Alzheimer's disease progression

Alzheimer's may progress more rapidly in people with high blood pressure or atrial fibrillation

Alzheimer's may progress more rapidly in people with high blood pressure or atrial fibrillation

Mortality rates 71 percent lower at top-rated hospitals

Mortality rates 71 percent lower at top-rated hospitals

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.